BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Genetown

  Insulet Corporation Raises Awareness for Diabetes Community During National Diabetes Awareness Month

  Earlier this year, Insulet announced that it will be establishing a direct local presence in Europe on July 1, 2018.

  November 1, 2017

   · 

  5 min read
• Genetown

  Hologic Launches the MyoSure MANUAL Device to Help Doctors Remove Intrauterine Tissue In-Office

  The MyoSure MANUAL device joins the MyoSure suite of gynecologic surgical products.

  November 1, 2017

   · 

  4 min read
• Pharm Country

  Advaxis to Receive $4.5 Million Through the New Jersey Economic Development Authority NOL Program

  The company anticipates it will be able to transfer this credit and receive $4.5 million in cash by the end of 2017.

  November 1, 2017

   · 

  3 min read
• Business

  ImmunoMet Appoints Benjamin R. Cowen, PhD, MBA, as CEO

  ImmunoMet Therapeutics today announced the appointment of Benjamin R. Cowen, PhD, MBA, as CEO, effective November 1, 2017.

  November 1, 2017

   · 

  3 min read
• Business

  Tenaya Therapeutics Appoints Tim Hoey, Ph.D. as CSO

  Dr. Hoey is a biopharmaceutical executive with over two decades of experience in the industry.

  November 1, 2017

   · 

  2 min read
• Business

  Kaleido Biosciences Adds Two Senior Leaders to Guide Next Phase of Growth

  Kaleido Biosciences announced today the appointment of John W. Davies, Ph.D. as chief technology officer and Michael D. Bruce, Ph.D. as senior vice president, project, portfolio and alliance management.

  November 1, 2017

   · 

  3 min read
• Pharm Country

  Syntimmune Announces Clinical Data from First-in-Human Trial of Lead Candidate SYNT001

  An abstract of the Phase Ia trial results was posted today on the ASH website in advance of a poster presentation of the data, which will take place during the 59th ASH Annual Meeting, to be held in Atlanta, December 9-12.

  November 1, 2017

   · 

  7 min read
• Business

  GlycoMimetics to Report Third-Quarter 2017 Financial Results on November 8, 2017

  GlycoMimetics announced today that it will host a conference call and webcast to provide a corporate update and report its third-quarter 2017 financial results on Wednesday, November 8, 2017, at 8:30 a.m. ET.

  November 1, 2017

   · 

  1 min read
• Pharm Country

  Servier and Pfizer Announce Preliminary Results of the First-in-Human Trials of UCART19 Will Be Presented at the 59th ASH Annual Meeting

  Results from the CALM (UCART19 in Advanced Lymphoid Malignancies) study will be shared as an oral presentation by Reuben Benjamin, principal investigator and consultant hematologist at King’s College Hospital, United Kingdom, on December 11 at 7.15 pm (EST).

  November 1, 2017

   · 

  8 min read
• Business

  Exelixis Announces Third Quarter 2017 Financial Results and Provides Corporate Update

  During the third quarter of 2017, CABOMETYX generated $90.4 million in net product revenue.

  November 1, 2017

   · 

  20 min read